Form D · Biotechnology
Precision Epigenomics Inc
Tucson, AZ · CIK 0002017642
Offering snapshot reported Sep 23, 2025 · SEC filing
- Reported sold
- $265K Offering amount: $2M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2025 | Initial | $265,000 | No comparison | 5 | SEC filing |
| Apr 1, 2024 | Initial | $1,117,795 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558377
Source: Form D, filed Sep 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Bernert | Director, Executive |
| Bernard W Futscher | Executive |
| Barnard W Futscher | Executive |
| Lisa Jensen Long | Executive |
| Matthew H Miller | Executive |
| Mark A Nelson | Director, Executive |
| Lisa Shaffer | Director |
| Marie Wesselhoft | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
630 N. Alvernon Way Suite 280 B
Tucson, AZ, 85711
Tucson, AZ, 85711